• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMO UPPSALA AB HEALON; AID, SURGICAL, VISCOELASTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMO UPPSALA AB HEALON; AID, SURGICAL, VISCOELASTIC Back to Search Results
Model Number HEALON GV
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Edema (1791); Endophthalmitis (1835); Hyphema (1911); Inflammation (1932); Intraocular Pressure Decreased (4468)
Event Type  Injury  
Manufacturer Narrative
Age/date of birth (months): ages range between 48.7-60.6 (ac group); 51.8-65.8 (pc group).Sex/gender: (male: female): 8:16 (ac group); 10:9 (pc group).Information unknown, not provided.Date of event: article acceptance date is february 15, 2021.Model number: partially known, as the lot number was not provided.A complete catalog number is unknown as the lot number was not provided.Lot number: unknown, information not provided.Expiration date: unknown, as the lot number was not provided.Udi number: a complete udi number is unknown, as the lot number was not provided.Implant date: not applicable as this is not an implantable device.Explant date: not applicable as this is not an implantable device.Device manufacture date: unknown, as the lot number was not provided.Device evaluation: the product testing could not be performed as the product was not returned.The reported complaint cannot be confirmed.Manufacturing record evaluation: the manufacturing record review could not be performed because the lot number of the complaint product is unknown.Since the lot number is unknown, the complaint history review could not be performed.Conclusion: since the sample of the complaint product was not returned, and lot number is unknown, it is not possible to determine a malfunction and/or product quality deficiency.Citation: huang, k.-h., chen, c.-l., lu, d.-w., chen, j.-t., chen, y.-h.(2021).Outcomes of small size ahmed glaucoma valve implantation in asian chronic angle-closure glaucoma.J.Clin.Med 10(4), 813, https://doi.Org/10.3390/jcm10040813.An attempt has been made to obtain missing information; however, to date, no response has been received.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event Description
The following article was received based on a literature review: article: outcomes of small size ahmed glaucoma valve implantation in asian chronic angle-closure glaucoma.A retrospective study was done to report the results of small size ahmed glaucoma valve (agv) insertion in adult chronic angle-closure glaucoma (acg) patients and evaluated the benefit and safety of modified technique (sclerectomy) for agv tube insertion to anterior chamber.A total of 43 eyes of 43 patients with chronic acg underwent small size agv insertion and were divided into anterior chamber (ac) group (n=24 eyes; 12 right and 12 left) and posterior chamber (pc) group (n=19 eyes; 6 right and 13 left).Anterior chamber paracentesis was made by micro vitreoretinal (mvr) blade and about 0.1 ml viscoelastic (healon gv, advanced medical optics) injection was performed through the paracentesis.In the ac group, 7 eyes were considered as failure in which 5 underwent second agv insertions, 1 underwent evisceration of the eyeball and 1 underwent a cyclodestructive procedure.In the pc group, 7 eyes were also considered as failure in which 5 underwent second agv implantations and 2 underwent cyclodestructive procedures.In the ac group, 12 patients showed no change in vision and 8 showed a decline.In the pc group, 11 showed no change in vision and 5 showed a decline.Post-operative complications in the ac group include: (n=1 eye) hyphema, (n=1 eye) flat chamber/hypotony, (n=3 eyes) encapsulated bleb, (n=1 eye) endophthalmitis, and (n=2 eyes) bullous keratopathy.Post-operative complications in the pc group include: (n=5 eye) hyphema, (n=1 eye) flat chamber/hypotony, (n=3 eyes) encapsulated bleb, and (n=1 eye) bullous keratopathy.Further interventions were not reported.Other jnj products were mentioned but no complaints were reported against them.A copy of the article is provided with this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEALON
Type of Device
AID, SURGICAL, VISCOELASTIC
Manufacturer (Section D)
AMO UPPSALA AB
rapsgatan 7
uppsala, uppsala län 754 5 0
SW  754 50
Manufacturer Contact
somyata nagpal
31 technology drive
irvine, CA 92618
7142478552
MDR Report Key12929880
MDR Text Key286762402
Report Number3012236936-2021-00143
Device Sequence Number1
Product Code LZP
UDI-Public(01)(10)UNKNOWN
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P810031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/03/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberHEALON GV
Device Catalogue Number10291960
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received11/04/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-